Your browser doesn't support javascript.
loading
Drug-like antibodies with high affinity, diversity and developability directly from next-generation antibody libraries.
Azevedo Reis Teixeira, Andre; Erasmus, Michael Frank; D'Angelo, Sara; Naranjo, Leslie; Ferrara, Fortunato; Leal-Lopes, Camila; Durrant, Oliver; Galmiche, Cecile; Morelli, Aleardo; Scott-Tucker, Anthony; Bradbury, Andrew Raymon Morton.
Affiliation
  • Azevedo Reis Teixeira A; New Mexico Consortium, Los Alamos, NM, USA.
  • Erasmus MF; Specifica Inc, Santa Fe, NM, USA.
  • D'Angelo S; Specifica Inc, Santa Fe, NM, USA.
  • Naranjo L; Specifica Inc, Santa Fe, NM, USA.
  • Ferrara F; Specifica Inc, Santa Fe, NM, USA.
  • Leal-Lopes C; New Mexico Consortium, Los Alamos, NM, USA.
  • Durrant O; UCB Pharma Ltd, Slough, UK.
  • Galmiche C; UCB Pharma Ltd, Slough, UK.
  • Morelli A; UCB Pharma Ltd, Slough, UK.
  • Scott-Tucker A; UCB Pharma Ltd, Slough, UK.
  • Bradbury ARM; Specifica Inc, Santa Fe, NM, USA.
MAbs ; 13(1): 1980942, 2021.
Article in En | MEDLINE | ID: mdl-34850665
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complementarity Determining Regions / Antibodies, Monoclonal Limits: Humans Language: En Journal: MAbs Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Complementarity Determining Regions / Antibodies, Monoclonal Limits: Humans Language: En Journal: MAbs Journal subject: ALERGIA E IMUNOLOGIA Year: 2021 Type: Article Affiliation country: United States